Do you want to read an article? Please log in or register.
Prevalence, course and psychosis-predictive value of negative symptoms in 22q11.2 deletion syndrome
Psychosis and Schizophrenia
Related content
Psychosis and Schizophrenia
Large-scale mapping of cortical alterations in 22q11.2 deletion syndrome: Convergence with idiopathic psychosis and effects of deletion size
Mol Psychiatry.
Sun D, Ching CRK, Lin A, Forsyth JK, Kushan L, Vajdi A, Jalbrzikowski M, Hansen L, Villalon-Reina JE, Qu X, Jonas RK, van Amelsvoort T, Bakker G, Kates WR, Antshel KM, Fremont W, Campbell LE, McCabe KL, Daly E, Gudbrandsen M, Murphy CM, Murphy D, Craig M, Vorstman J, Fiksinski A, Koops S, Ruparel K, Roalf DR, Gur RE, Schmitt JE, Simon TJ, Goodrich-Hunsaker NJ, Durdle CA, Bassett AS, Chow EWC, Butcher NJ, Vila-Rodriguez F, Doherty J, Cunningham A, van den Bree MBM, Linden DEJ, Moss H, Owen MJ, Murphy KC, McDonald-McGinn DM, Emanuel B, van Erp TGM, Turner JA, Thompson PM, Bearden CE
doi: 10.1038/s41380-018-0078-5.
EpilepsyParkinson’s DiseaseAnxiety and DepressionAutismPsychosis and SchizophreniaAttention Deficit Hyperactivity Disorder (ADHD)
Neurobiological perspective of 22q11.2 deletion syndrome
Lancet Psychiatry.
Zinkstok JR, Boot E, Bassett AS, Hiroi N, Butcher NJ, Vingerhoets C, Vorstman JAS, van Amelsvoort TAMJ
doi: 10.1016/S2215-0366(19)30076-8.
Psychosis and Schizophrenia
Age effect on prevalence of ultra-high risk for psychosis symptoms: replication in a clinical sample of an early detection of psychosis service
Eur Child Adolesc Psychiatry.
Schultze-Lutter F, Hubl D, Schimmelmann BG, Michel C
doi: 10.1007/s00787-017-0994-y.
Psychosis and Schizophrenia
Magnitude and heterogeneity of brain structural abnormalities in 22q11.2 deletion syndrome: a meta-analysis
Mol Psychiatry.
Rogdaki M, Gudbrandsen M, McCutcheon RA, Blackmore CE, Brugger S, Ecker C, Craig MC, Daly E, Murphy DGM, Howes O
doi: 10.1038/s41380-019-0638-3.
AutismPsychosis and Schizophrenia
Risk of Psychiatric Disorders Among Individuals With the 22q11.2 Deletion or Duplication: A Danish Nationwide, Register-Based Study
JAMA Psychiatry.
Hoeffding LK, Trabjerg BB, Olsen L, Mazin W, Sparsø T, Vangkilde A, Mortensen PB, Pedersen CB, Werge T
doi: 10.1001/
Psychosis and Schizophrenia
Systematic Review and Multi-Modal Meta-Analysis of Magnetic Resonance Imaging Findings in 22q11.2 Deletion Syndrome: is more evidence needed?
Neurosci Biobehav Rev.
Scarpazza C, Lattanzi GM, Antoniades M, Di Fabio F, Sartori G, Eickhoff SB, McGuire P, Tognin S
doi: 10.1016/j.neubiorev.2019.09.004.
Anxiety and DepressionPsychosis and Schizophrenia
Course of psychotic symptoms, depression and global functioning in persons at clinical high risk of psychosis: Results of a longitudinal observation study over three years focusing on both converters and non-converters
Schizophr Res.
Hengartner MP, Heekeren K, Dvorsky D, Walitza S, Rössler W, Theodoridou A
doi: 10.1016/j.schres.2017.01.040.
EpilepsyAnxiety and Depression
Typical features of Parkinson disease and diagnostic challenges with microdeletion 22q11.2
Neurology.
Boot E, Butcher NJ, Udow S, Marras C, Mok KY, Kaneko S, Barrett MJ, Prontera P, Berman BD, Masellis M, Dufournet B, Nguyen K, Charles P, Mutez E, Danaila T, Jacquette A, Colin O, Drapier S, Borg M, Fiksinski AM, Vergaelen E, Swillen A, Vogels A, Plate A, Perandones C, Gasser T, Clerinx K, Bourdain F, Mills K, Williams NM, Wood NW, Booij J, Lang AE, Bassett AS; International Research Group on 22q11.2DS-associated Parkinson's Disease
doi: 10.1212/
Psychosis and Schizophrenia
Genetic contributors to risk of schizophrenia in the presence of a 22q11.2 deletion
Mol Psychiatry.
Cleynen I, Engchuan W, Hestand MS, Heung T, Holleman AM, Johnston HR, Monfeuga T, McDonald-McGinn DM, Gur RE, Morrow BE, Swillen A, Vorstman JAS, Bearden CE, Chow EWC, van den Bree M, Emanuel BS, Vermeesch JR, Warren ST, Owen MJ, Chopra P, Cutler DJ, Duncan R, Kotlar AV, Mulle JG, Voss AJ, Zwick ME, Diacou A, Golden A, Guo T, Lin JR, Wang T, Zhang Z, Zhao Y, Marshall C, Merico D, Jin A, Lilley B, Salmons HI, Tran O, Holmans P, Pardinas A, Walters JTR, Demaerel W, Boot E, Butcher NJ, Costain GA, Lowther C, Evers R, van Amelsvoort TAMJ, van Duin E, Vingerhoets C, Breckpot J, Devriendt K, Vergaelen E, Vogels A, Crowley TB, McGinn DE, Moss EM, Sharkus RJ, Unolt M, Zackai EH, Calkins ME, Gallagher RS, Gur RC, Tang SX, Fritsch R, Ornstein C, Repetto GM, Breetvelt E, Duijff SN, Fiksinski A, Moss H, Niarchou M, Murphy KC, Prasad SE, Daly EM, Gudbrandsen M, Murphy CM, Murphy DG, Buzzanca A, Fabio FD, Digilio MC, Pontillo M, Marino B, Vicari S, Coleman K, Cubells JF, Ousley OY, Carmel M, Gothelf D, Mekori-Domachevsky E, Michaelovsky E, Weinberger R, Weizman A, Kushan L, Jalbrzikowski M, Armando M, Eliez S, Sandini C, Schneider M, Béna FS, Antshel KM, Fremont W, Kates WR, Belzeaux R, Busa T, Philip N, Campbell LE, McCabe KL, Hooper SR, Schoch K, Shashi V, Simon TJ, Tassone F, Arango C, Fraguas D, García-Miñaúr S, Morey-Canyelles J, Rosell J, Suñer DH, Raventos-Simic J, International 22q11.2DS Brain and Behavior Consortium., Epstein MP, Williams NM, Bassett AS
doi: 10.1038/s41380-020-0654-3.